Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 483

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Open access
Jager, Kitty J., Kramer, Anneke, Chesnaye, Nicholas C., Couchoud, Cécile, Sánchez-Álvarez, J. Emilio, Garneata, Liliana, Collart, Fréderic, Hemmelder, Marc H., Ambühl, Patrice, Kerschbaum, Julia, Legeai, Camille, del Pino y Pino, María Dolores, Mircescu, Gabriel, Mazzoleni, Lionel, Hoekstra, Tiny, Winzeler, Rebecca, Mayer, Gert, Stel, Vianda S., Wanner, Christoph, Zoccali, Carmine, Massy, Ziad A.·2020·Kidney International

Abstract

The aim of this study was to investigate 28-day mortality after COVID-19 diagnosis in the European kidney replacement therapy population. In addition, we determined the role of patient characteristics, treatment factors, and country on mortality risk with the use of ERA-EDTA Registry data on patients receiving kidney replacement therapy in Europe from February 1, 2020, to April 30, 2020. Additional data on all patients with a diagnosis of COVID-19 were collected from 7 European countries encompassing 4298 patients. COVID-19-attributable mortality was calculated using propensity score-matched historic control data and after 28 days of follow-up was 20.0% (95% confidence interval 18.7%-21.4%) in 3285 patients receiving dialysis and 19.9% (17.5%-22.5%) in 1013 recipients of a transplant. We identified differences in COVID-19 mortality across countries, and an increased mortality risk in older patients receiving kidney replacement therapy and male patients receiving dialysis. In recipients of kidney transplants ≥75 years of age, 44.3% (35.7%-53.9%) did not survive COVID-19. Mortality risk was 1.28 (1.02-1.60) times higher in transplant recipients compared with matched dialysis patients. Thus, the pandemic has had a substantial effect on mortality in patients receiving kidney replacement therapy, a highly vulnerable population due to underlying chronic kidney disease and a high prevalence of multimorbidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.kint.2020.09.006

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 483

Metadata

Authors
Jager, K. J., Kramer, A., Chesnaye, N. C., Couchoud, C., Sánchez-Álvarez, J. E., Garneata, L., Collart, F., Hemmelder, M. H., Ambühl, P., Kerschbaum, J., Legeai, C., del Pino y Pino, M. D., Mircescu, G., Mazzoleni, L., Hoekstra, T., Winzeler, R., Mayer, G., Stel, V. S., Wanner, C., Zoccali, C., & Massy, Z. A.
Venue
Kidney International
Publisher
Elsevier BV
Published
2020-12
Volume
98
Issue
6
Pages
1540-1548
ISSN
0085-2538 (ISSN-L)
OpenAlex
W3087816957
Cited by
483
References
13
FWCI
12.04
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. https://app.cochat.ai/papers/10.1016/j.kint.2020.09.006
The paper
Jager, K. J., Kramer, A., Chesnaye, N. C., Couchoud, C., Sánchez-Álvarez, J. E., Garneata, L., Collart, F., Hemmelder, M. H., Ambühl, P., Kerschbaum, J., Legeai, C., del Pino y Pino, M. D., Mircescu, G., Mazzoleni, L., Hoekstra, T., Winzeler, R., Mayer, G., Stel, V. S., Wanner, C., . . . Massy, Z. A. (2020). Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney International. https://doi.org/10.1016/j.kint.2020.09.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.